|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 19/00 | (2006.01) |
| A61K 38/16 | (2006.01) | ||
| A61K 38/45 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K 16/00 | (2006.01) | ||
| C12N 15/62 | (2006.01) | ||
| A61K 38/00 | (2006.01) |
| (11) | Number of the document | 2931752 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13865442.1 |
| Date of filing the European patent application | 2013-12-17 | |
| (97) | Date of publication of the European application | 2015-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-14 |
| (46) | Date of publication of the claims translation | 2019-12-10 |
| (86) | Number | PCT/CA2013/001046 |
| Date | 2013-12-17 |
| (87) | Number | WO 2014/094122 |
| Date | 2014-06-26 |
| (30) | Number | Date | Country code |
| 201261738008 P | 2012-12-17 | US |
| (72) |
UGER, Robert Adam, CA
SLAVOVA-PETROVA, Penka Slavtcheva, CA
PANG, Xinli, CA
|
| (73) |
Pfizer Inc.,
66 Hudson Boulevard East, New York, N.Y. 10001-2192,
US
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ligos CD47+ ląstelių gydymas su SIRP alfa-Fc junginiais |
| TREATMENT OF CD47+ DISEASE CELLS WITH SIRP ALPHA-FC FUSIONS |
| Payment date | Validity (years) | Amount | |
| 2024-11-12 | 12 | 289.00 EUR |
| 2025-12-17 |